260 related articles for article (PubMed ID: 17938324)
21. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
[TBL] [Abstract][Full Text] [Related]
22. Papillary thyroid cancer: high inter-(simple sequence repeat) genomic instability in a typically indolent cancer.
Wiseman SM; Loree TR; Rigual NR; Hicks WL; Winston JS; Swede H; Bartos JD; Anderson GR; Stoler DL
Head Neck; 2003 Oct; 25(10):825-32. PubMed ID: 12966506
[TBL] [Abstract][Full Text] [Related]
23. Molecular prognosticators and genomic instability in papillary thyroid cancer.
Rigual NR; Anderson GR; Loree TR; Wiseman S; Alrawi S; Stoler DL
Laryngoscope; 2005 Aug; 115(8):1479-85. PubMed ID: 16094129
[TBL] [Abstract][Full Text] [Related]
24. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
[TBL] [Abstract][Full Text] [Related]
25. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.
D'Agostino M; Sponziello M; Puppin C; Celano M; Maggisano V; Baldan F; Biffoni M; Bulotta S; Durante C; Filetti S; Damante G; Russo D
J Mol Endocrinol; 2014 Apr; 52(2):121-31. PubMed ID: 24353283
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
27. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
28. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
29. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.
Wang ZF; Liu QJ; Liao SQ; Yang R; Ge T; He X; Tian CP; Liu W
Tumori; 2011; 97(4):540-6. PubMed ID: 21989446
[TBL] [Abstract][Full Text] [Related]
30. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
[TBL] [Abstract][Full Text] [Related]
31. Cribriform-morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma. A case report with clinical and molecular genetic correlation.
Ng SB; Sittampalam K; Goh YH; Eu KW
Pathology; 2003 Feb; 35(1):42-6. PubMed ID: 12701683
[TBL] [Abstract][Full Text] [Related]
32. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
[TBL] [Abstract][Full Text] [Related]
33. Tumor proliferation-related markers in papillary thyroid carcinomas: correlation with histologic subtypes.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1993; 13(1):267-71. PubMed ID: 8097390
[TBL] [Abstract][Full Text] [Related]
34. DNA hypermethylation status of multiple genes in papillary thyroid carcinomas.
Ishida E; Nakamura M; Shimada K; Higuchi T; Takatsu K; Yane K; Konishi N
Pathobiology; 2007; 74(6):344-52. PubMed ID: 18087199
[TBL] [Abstract][Full Text] [Related]
35. Biological behavior and prognosis of familial papillary thyroid carcinoma.
Ito Y; Kakudo K; Hirokawa M; Fukushima M; Yabuta T; Tomoda C; Inoue H; Kihara M; Higashiyama T; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
Surgery; 2009 Jan; 145(1):100-5. PubMed ID: 19081481
[TBL] [Abstract][Full Text] [Related]
36. [Relationship of methylation of promoter and expression of PTEN gene in papillary thyroid carcinoma].
Yin DT; Yin FY; Zheng LY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Apr; 45(4):330-3. PubMed ID: 20627056
[No Abstract] [Full Text] [Related]
37. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.
Shattuck TM; Westra WH; Ladenson PW; Arnold A
N Engl J Med; 2005 Jun; 352(23):2406-12. PubMed ID: 15944425
[TBL] [Abstract][Full Text] [Related]
38. TSH receptor status of thyroid neoplasms--TaqMan RT-PCR analysis of archival material.
Sheils OM; Sweeney EC
J Pathol; 1999 May; 188(1):87-92. PubMed ID: 10398146
[TBL] [Abstract][Full Text] [Related]
39. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
40. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]